By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Medical Answers > How do you apply clobetasol propionate for lichen sclerosus?

How do you apply clobetasol propionate for lichen sclerosus?

Answers by TheMediTary.Com - Last updated: 12-Jul-2023

To treat lichen sclerosus, apply a small amount (0.5g or one fingertip unit) of clobetasol propionate thinly, once a day to the affected area, for up to 12 weeks or as directed by your doctor. Rub it in gently. Do not apply this medicine over a large area of skin unless your doctor has told you to.

Once this baseline treatment course has finished, clobetasol propionate may be continued to be used sporadically as needed to stem any recurrence in symptoms, if this course of action has been recommended by your doctor. Do not keep applying clobetasol propionate for long periods continuously without the advice of your doctor.

Clobetasol propionate ointment is usually preferable for cream as it will adhere to the affected area for longer.

Clobetasol propionate is an ultra-potent (also called a super potent) corticosteroid and research has shown that treatment for 12 weeks significantly improves symptoms of lichen sclerosus in 75% to 90% of patients, compared to only 10% of patients given a placebo ointment (a pretend ointment).

Untreated lichen sclerosus is associated with a greater degree of scarring and an elevated risk of cancer in the genital area. Topical calcineurin inhibitors, such as pimecrolimus or tacrolimus, may be considered as second-line treatment. If treatment is unsuccessful in boys and men, circumcision may be considered.

What is lichen sclerosus?

Lichen sclerosus is a common skin condition that most often affects the genital or perianal regions.

It is ten times more common in women than men and usually affects women over the age of 50. Children can also be affected, and it commonly runs in families, with 15% reporting another family member with the condition. It often co-exists with an autoimmune disorder such as thyroid disease, pernicious anemia, alopecia areata, or another skin condition such as psoriasis, lichen simplex (a well-defined area of thickened skin resulting from repeated rubbing, itching, and scratching of the skin), vitiligo (an acquired depigmenting disorder of the skin) or morphea (a thickening of the skin due to excessive collagen deposition).

Symptoms of lichen sclerosus include itching (96%), irritation (61%), burning, and dyspareunia (pain during sexual intercourse). It most commonly affects the labia, clitoris, perineum, and less commonly the perianal region.

Lichen sclerosus can start at any age, although it is most often diagnosed in women over 50. Pre-pubertal children can also be affected.

Share this Article

Featured questions

  • Can clobetasol be used for toenail fungus?
  • Does clobetasol cause hair loss or growth?
  • What is clobetasol propionate cream used for?
  • Can clobetasol propionate be used for poison ivy?
  • How long does clobetasol stay in your system?
  • How effective is clobetasol for hair growth?
  • How long should you use clobetasol propionate cream for?
  • Can clobetasol make you gain weight?
  • Can these drugs be used in Thalassemia patients?
  • How does Lupron (leuprolide) work for prostate cancer?
  • What is the consideration to use nifidepine over amlodipine?
  • Hypertrophic cardiomyopathy/mechanical heart valve?
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch (Hydrocortisone topical)
Centrum Adult (Multivitamins and minerals)
Crovalimab
Cyltezo Prefilled Syringe (Adalimumab)
Zepbound Pen (Tirzepatide)
Mylanta One (Calcium carbonate, magnesium hydroxide, and simethicone)
Uretron Ds (Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate)
Medihoney Wound And Burn Dressing (Topical emollients)
Lidotrode
Libervant (Diazepam (buccal))
Moderna Covid-19 (Covid-19 (6m-11y) vaccine, moderna (2024-2025))
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by